Lista publicaţiilor: Robak Tadeusz (1), Descărcări - 0, Vizualizări - 480
Publicații cu DOI
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia |
Robak Tadeusz, Kazmierczak Maciej, Jarque Isidro, Musteaţă Vasile, Trelinski Jacek, Cooper Nichola, Kiessling Peter C., Massow Ute, Woltering Franz, Snipes Rose G., Ke Juan, Langdon Grant, Bussel James Bruce, Jolles Stephen |
Blood Advances |
Nr. 4 / 2020 / ISSN 2473-9537 |
Disponibil online 15 March, 2021. Descarcări-0. Vizualizări-480 |